Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

INTRODUCTION: Lung cancer is the leading cause of cancer mortality worldwide, despite advances in management, especially with targeted agents and immunotherapy. Numerous oncogenes have been identified that control the growth of these malignancies. Anaplastic lymphoma kinase (ALK) is a tyrosine kinas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Manag Res
Main Authors: Mohieldin, Ahmed, Rasmy, Ayman, Ashour, Mohamed, Al-Nassar, Muath, Ali, Rola H, El-Enezi, Fahad G
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6278708/
https://ncbi.nlm.nih.gov/pubmed/30555260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S173084
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki